Estados financieros detallados de Co-Diagnostics, Inc. (CODX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Co-Diagnostics, Inc. registró ingresos de $622489 en el último ejercicio fiscal, con un CAGR de 5 años del -61.6%.
Márgenes de los últimos 12 meses: margen bruto 8.1%, margen operativo -41.7%, margen neto -65.2%.
Al precio actual de $0.94, CODX presenta beneficios negativos (P/E no significativo) y un ROE del -210.99%. La capitalización bursátil es de $1M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | $7662 | $39911 | $214974 | $74.6M | $97.9M | $34.2M | $6.8M | $3.9M | $622489 |
| Coste de Ventas | $37491 | $302 | $9391 | $112431 | $16.6M | $11.6M | $5.5M | $4.2M | $999124 | $222377 |
| Beneficio Bruto | -$37491 | $7360 | $30520 | $102543 | $58.0M | $86.3M | $28.7M | $2.6M | $2.9M | $400112 |
| I+D | $731474 | $1.0M | $1.4M | $1.4M | $3.2M | $15.0M | $17.4M | $23.0M | $21.0M | $19.1M |
| Generales y Administrativos | $919000 | $3.5M | $4.7M | $4.6M | $12.9M | $24.9M | $21.6M | $21.1M | $20.6M | $11.4M |
| Gastos Operativos | $1.7M | $4.6M | $6.1M | $6.0M | $16.3M | $40.2M | $55.7M | $45.3M | $43.0M | $31.7M |
| Beneficio Operativo | -$1.7M | -$4.6M | -$6.1M | -$5.9M | $41.7M | $46.1M | -$27.0M | -$42.7M | -$40.1M | -$31.3M |
| EBITDA | -$1.7M | -$6.6M | -$6.1M | -$6.0M | $41.8M | $46.0M | -$10.3M | -$36.9M | -$36.2M | -$47.4M |
| Gastos por Intereses | $240720 | $310233 | $134947 | $106437 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$1.9M | -$7.0M | -$6.3M | -$6.2M | $42.6M | $45.6M | -$18.8M | -$38.1M | -$37.6M | -$48.5M |
| Impuestos | 0 | 0 | -$18960 | 0 | $90536 | $9.0M | -$4.6M | -$2.8M | $57368 | -$1.6M |
| Beneficio Neto | -$1.9M | -$7.0M | -$6.3M | -$6.2M | $42.5M | $36.7M | -$14.2M | -$35.3M | -$37.6M | -$46.9M |
| BPA | $-5.10 | $-18.90 | $-15.00 | $-11.09 | $1.59 | $38.10 | $-13.57 | $-36.00 | $-37.20 | $-35.25 |
| BPA Diluido | $-5.10 | $-18.90 | $-15.00 | $-11.09 | $1.52 | $36.90 | $-13.57 | $-36.00 | $-37.20 | $-35.25 |
| Acciones en Circulación (Diluidas) | $372739 | $365344 | $416154 | $558564 | $933345 | $996790 | $1.0M | $978220 | $1.0M | $1.3M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $145380 | $263922 | $145954 | $166131 |
| Beneficio Bruto | $119095 | $121526 | -$303259 | $120828 |
| Beneficio Operativo | -$7.0M | -$7.7M | -$9.2M | -$6.2M |
| EBITDA | -$6.8M | -$26.0M | -$8.9M | -$5.9M |
| Beneficio Neto | -$5.9M | -$25.7M | -$9.1M | -$6.3M |
| BPA | $-4.66 | $-16.54 | $-4.06 | $-1.46 |
| BPA Diluido | $-4.66 | $-16.54 | $-4.06 | $-1.46 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $998737 | $3.5M | $950237 | $893138 | $43.0M | $88.6M | $23.0M | $14.9M | $2.9M | $11.9M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | $4.3M | $1.3M | $58.3M | $43.6M | $26.8M | 0 |
| Cuentas por Cobrar | $3183 | 0 | $13420 | $131382 | $12.1M | $20.9M | $5.4M | $330881 | $132570 | $190375 |
| Inventario | 0 | $9068 | $18153 | $197168 | $8.0M | $2.0M | $5.3M | $1.7M | $1.1M | $992397 |
| Activos Corrientes | $1.2M | $4.5M | $1.1M | $1.6M | $68.4M | $115.1M | $92.7M | $62.1M | $32.3M | $13.7M |
| Inmovilizado Material | $87429 | $165567 | $156138 | $196832 | $949639 | $1.9M | $2.9M | $6.0M | $4.9M | $3.5M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | $14.7M | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | $27.2M | $26.8M | $26.4M | $26.1M | $7.2M |
| Activos Totales | $1.3M | $4.7M | $1.6M | $2.2M | $71.2M | $160.0M | $123.1M | $95.3M | $64.0M | $24.7M |
| Cuentas por Pagar | $104934 | $40819 | $148967 | $5959 | $598318 | $607506 | $952296 | $1.5M | $3.3M | $1.9M |
| Deuda a Corto | $2.9M | 0 | $1.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $3.8M | $628256 | $2.4M | $328070 | $4.1M | $12.6M | $3.9M | $5.7M | $7.3M | $3.5M |
| Deuda a Largo | $445000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $574301 |
| Pasivos Totales | $4.3M | $811802 | $2.6M | $478070 | $4.5M | $25.6M | $8.6M | $9.3M | $9.7M | $4.1M |
| Reservas | -$5.5M | -$12.4M | -$18.7M | -$25.0M | $17.5M | $54.2M | $39.9M | $4.6M | -$33.0M | -$80.4M |
| Patrimonio Neto | -$3.0M | $3.9M | -$1.1M | $1.7M | $66.7M | $134.5M | $114.5M | $86.0M | $54.3M | $20.6M |
| Deuda Total | $3.4M | 0 | $1.9M | 0 | 0 | 0 | $347917 | $3.0M | $2.2M | $1.2M |
| Deuda Neta | $2.4M | -$3.5M | $958335 | -$893138 | -$47.3M | -$89.9M | -$80.9M | -$55.6M | -$27.6M | -$10.6M |
| Capital Circulante | -$2.6M | $3.8M | -$1.3M | $1.3M | $64.3M | $102.5M | $88.9M | $56.4M | $25.0M | $10.2M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $11.4M | $11.9M | $8.2M | $3.6M |
| Activos Totales | $44.7M | $24.7M | $21.5M | $16.6M |
| Pasivos Totales | $4.9M | $4.1M | $5.5M | $3.9M |
| Patrimonio Neto | $39.8M | $20.6M | $16.0M | $12.7M |
| Deuda Total | $1.5M | $1.2M | $2.0M | $1.8M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$1.9M | -$7.0M | -$6.3M | -$6.2M | $42.5M | $36.7M | -$14.2M | -$35.3M | -$37.6M | -$46.9M |
| Amortizaciones | $37491 | $45758 | $50765 | $65902 | $138635 | $335363 | $1.3M | $1.2M | $1.4M | $1.1M |
| Compensación en Acciones | $69565 | $2.0M | $1.3M | $1.1M | $2.7M | $5.5M | $7.5M | $8.3M | $5.4M | $2.2M |
| Cambio en Capital Circulante | $487847 | -$504747 | $769770 | -$818281 | -$16.8M | -$2.9M | $6.2M | $5.6M | $2.8M | -$3.2M |
| Flujo de Caja Operativo | -$1.3M | -$3.2M | -$4.1M | -$5.5M | $28.2M | $41.1M | $6.6M | -$22.1M | -$29.2M | -$29.1M |
| Inversiones (CapEx) | -$12241 | -$129306 | -$41336 | -$113246 | -$774397 | -$669463 | -$1.4M | -$1.4M | -$748352 | -$700047 |
| Adquisiciones | 0 | 0 | 0 | -$322000 | -$714500 | $1.7M | 0 | 0 | -$143750 | -$102566 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | -$14.2M | -$1.4M | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$1.3M | -$3.3M | -$4.1M | -$5.6M | $27.4M | $40.4M | $5.1M | -$23.4M | -$29.9M | -$29.8M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$5.9M | -$6.2M | -$7.8M | -$7.2M |
| Inversiones (CapEx) | -$75105 | -$131969 | -$142017 | -$18281 |
| Flujo de Caja Libre | -$6.0M | -$6.3M | -$8.0M | -$7.2M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $500585 | $291975 | $219114 | $213752 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | +420.9% | +438.6% | +34579.9% | +31.3% | -65.0% | -80.1% | -42.5% | -84.1% |
| Crecimiento Beneficio Neto (anual) | | -260.8% | +9.9% | +1.2% | +785.6% | -13.7% | -138.8% | -148.2% | -6.5% | -24.6% |
| Crecimiento BPA (anual) | | -270.6% | +20.6% | +26.1% | +114.3% | +2296.2% | -135.6% | -165.3% | -3.3% | +5.2% |
| Cambio en Acciones (anual) | | -2.0% | +13.9% | +34.2% | +67.1% | +6.8% | +5.3% | -6.8% | +3.4% | +31.5% |
| Crecimiento FCF (anual) | | -152.2% | -23.4% | -36.8% | +585.8% | +47.5% | -87.3% | -556.1% | -27.5% | +0.2% |
| Margen Bruto | | 96.1% | 76.5% | 47.7% | 77.7% | 88.2% | 84.0% | 38.6% | 74.5% | 64.3% |
| Margen Operativo | | -59567.6% | -15328.6% | -2741.6% | 55.9% | 47.1% | -78.8% | -626.9% | -1023.7% | -5025.5% |
| Margen EBITDA | | -86177.7% | -15249.0% | -2801.8% | 56.1% | 47.0% | -30.1% | -541.4% | -924.7% | -7615.4% |
| Margen Neto | | -90827.9% | -15714.3% | -2882.0% | 57.0% | 37.5% | -41.6% | -518.7% | -961.4% | -7533.6% |
| Margen FCF | | -43601.0% | -10326.4% | -2622.8% | 36.7% | 41.3% | 15.0% | -344.2% | -763.8% | -4793.2% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | 0.3% | -0.0% | 0.2% | 19.7% | 24.5% | 7.3% | -0.2% | 3.3% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-3.55 | $-9.14 | $-9.90 | $-10.09 | $29.35 | $40.54 | $4.90 | $-23.97 | $-29.57 | $-22.43 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $368698 | $365344 | $416154 | $558564 | $890671 | $962485 | $1.0M | $978220 | $1.0M | $1.3M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -210.99% |
| Rentabilidad sobre capital invertido | -200.40% |
| Rentabilidad sobre activos | -283.63% |
| Margen bruto | 8.07% |
| Margen operativo | -4170.14% |
| Margen neto | -6523.04% |
Salud financiera
| Deuda / Patrimonio | 0.14 |
| Ratio corriente | 1.81 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -7.22 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -34.18 | -4.19 | -2.98 | -2.42 | 175.47 | 7.03 | -5.57 | -1.11 | -0.60 | -0.14 |
| P/VC | -21.46 | 7.51 | -17.57 | 8.63 | 3.73 | 1.92 | 0.69 | 0.45 | 0.42 | 0.33 |
| P/V | 0.00 | 3776.46 | 466.09 | 69.76 | 3.33 | 2.63 | 2.32 | 5.73 | 5.81 | 10.83 |
| Margen Bruto | 0.0% | 96.1% | 76.5% | 47.7% | 77.7% | 88.2% | 84.0% | 38.6% | 74.5% | 64.3% |
| Margen Operativo | 0.0% | -59567.6% | -15328.6% | -2741.6% | 55.9% | 47.1% | -78.8% | -626.9% | -1023.7% | -5025.5% |
| Margen Neto | 0.0% | -90827.9% | -15714.3% | -2882.0% | 57.0% | 37.5% | -41.6% | -518.7% | -961.4% | -7533.6% |